101 related articles for article (PubMed ID: 7581715)
21. [Radioimmunotherapy of lymphomas and leukemias].
Rain JD; Billotey C
Pathol Biol (Paris); 1998 May; 46(5):341-5. PubMed ID: 9769896
[TBL] [Abstract][Full Text] [Related]
22. Pharmaceutical quality control of radiolabeled monoclonal antibodies and their fragments.
DeNardo SJ; DeNardo GL; Peng JS
Am J Physiol Imaging; 1989; 4(1):39-44. PubMed ID: 2647112
[TBL] [Abstract][Full Text] [Related]
23. Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein.
Buchsbaum DJ; Khazaeli MB; Axworthy DB; Schultz J; Chaudhuri TR; Zinn KR; Carpenter M; LoBuglio AF
Clin Cancer Res; 2005 Nov; 11(22):8180-5. PubMed ID: 16299250
[TBL] [Abstract][Full Text] [Related]
24. Doubly radiolabeled liposomes for pretargeted radioimmunotherapy.
Mougin-Degraef M; Bourdeau C; Jestin E; Saï-Maurel C; Bourgeois M; Saëc PR; Thédrez P; Gestin JF; Barbet J; Faivre-Chauvet A
Int J Pharm; 2007 Nov; 344(1-2):110-7. PubMed ID: 17592745
[TBL] [Abstract][Full Text] [Related]
25. The promise of targeted {alpha}-particle therapy.
Mulford DA; Scheinberg DA; Jurcic JG
J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670
[TBL] [Abstract][Full Text] [Related]
26. Radiolabeling and targeting of lipidic nanocapsules for applications in radioimmunotherapy.
Jestin E; Mougin-Degraef M; Faivre-Chauvet A; Remaud-Le Saëc P; Hindre F; Benoit JP; Chatal JF; Barbet J; Gestin JF
Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):51-60. PubMed ID: 17372573
[TBL] [Abstract][Full Text] [Related]
27. Copper-67 as a therapeutic nuclide for radioimmunotherapy.
Novak-Hofer I; Schubiger PA
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):821-30. PubMed ID: 12029558
[TBL] [Abstract][Full Text] [Related]
28. Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods.
Sharkey RM; Karacay H; Cardillo TM; Chang CH; McBride WJ; Rossi EA; Horak ID; Goldenberg DM
Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7109s-7121s. PubMed ID: 16203810
[TBL] [Abstract][Full Text] [Related]
29. Fast and specific labeling of antibody fragments with multiple atoms of heavy metal radioisotopes.
Trubetskoy VS; Torchilin VP
Anal Biochem; 1995 Aug; 229(2):345-7. PubMed ID: 7485993
[No Abstract] [Full Text] [Related]
30. Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: results of a phase I clinical trial.
DeNardo SJ; Kramer EL; O'Donnell RT; Richman CM; Salako QA; Shen S; Noz M; Glenn SD; Ceriani RL; DeNardo GL
J Nucl Med; 1997 Aug; 38(8):1180-5. PubMed ID: 9255145
[TBL] [Abstract][Full Text] [Related]
31. New approaches to radiolabeling monoclonal antibodies.
Zimmer AM; Spies SM
Cancer Treat Res; 1993; 68():99-109. PubMed ID: 8105854
[No Abstract] [Full Text] [Related]
32. Regressive DOTA labelling performance with indium-111 and yttrium-90 over a week of use.
Hainsworth JE; Mather SJ
Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1348. PubMed ID: 16142470
[No Abstract] [Full Text] [Related]
33. Cell-penetrating peptides and antibodies: a new direction for optimizing radioimmunotherapy.
Jain M; Venkatraman G; Batra SK
Eur J Nucl Med Mol Imaging; 2007 Jul; 34(7):973-7. PubMed ID: 17453198
[No Abstract] [Full Text] [Related]
34. Radiolabeling of antibodies.
Eckelman WC; Paik CH; Reba RC
Cancer Res; 1980 Aug; 40(8 Pt 2):3036-42. PubMed ID: 7397697
[TBL] [Abstract][Full Text] [Related]
35. Radioimmunodiagnosis and therapy.
Verhaar-Langereis MJ; Zonnenberg BA; de Klerk JM; Blijham GH
Cancer Treat Rev; 2000 Feb; 26(1):3-10. PubMed ID: 10660488
[TBL] [Abstract][Full Text] [Related]
36. [Monoclonal antibodies. An approach to diagnosis and treatment of micrometastases].
Bier H
HNO; 1994 May; 42(5):255-6. PubMed ID: 8050912
[No Abstract] [Full Text] [Related]
37. Granulocyte kinetics and methods of evaluating cell performance.
Peters AM
Nucl Med Commun; 1988 Oct; 9(10):687-92. PubMed ID: 3062506
[No Abstract] [Full Text] [Related]
38. Search for new and improved radiolabeling methods for monoclonal antibodies. A review of different methods.
Hiltunen JV
Acta Oncol; 1993; 32(7-8):831-9. PubMed ID: 8305233
[TBL] [Abstract][Full Text] [Related]
39. Radiolabeled monoclonal antibodies: radiochemical pharmacokinetic and clinical challenges.
Gobuty AH; Kim EE; Weiner RE
J Nucl Med; 1985 May; 26(5):546-8. PubMed ID: 3989609
[No Abstract] [Full Text] [Related]
40. A model for others: a strategy for improving diagnosis and therapy of human malignancies using monoclonal antibodies targeting TAG-72 oncofetal antigen.
Larson SM
Cancer Invest; 1993; 11(2):235-8. PubMed ID: 8462025
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
